The market downturn will create opportunities for more M&A, Devin Carty, the CEO of Martin Ventures, saysDevin Carty.
Martin VenturesIf 2021 was the year of big venture checks and wildly oversize valuations among healthcare startups, 2022 was when it all came crashing back to earth.
But the down economy will be an opportunity for venture-capital and private-equity firms, said Carty.
His Nashville, Tennessee, venture-capital firm invests in and launches healthcare startups, including companies transforming primary care, such as Wellvana, or kidney care, such as Evergreen Nephrology.
So far in 2022, the firm invested in six new companies and nine startups already in its portfolio.